The audit process tested and proved Finar's commitment to deliver safe and premium quality products to the market, the scope relating to the manufacture of pharmaceutical excipients: solvents and excipients for use in injectables, oral solid/semi-solid dosages, topical, ophthalmic and transdermal patches.
Jeff Dowson, SGS Global Head of International Sales and Accounts, commented on Finar Limited's certification, and said: "The pharmaceutical supply chain constantly faces risks in safety and continues to meet market demands without compromising quality. Companies like Finar Limited prove that pharmaceutical companies respond to these challenges by becoming EXCiPACT-certified. It was a privilege to be a part of this certification process, where we were able to demonstrate our audit expertise while also showing our dedication for assuring safety, quality and risk-reduction to the supply chain."
Both the auditors of SGS and Finar entered an exhaustive assessment process to become EXCiPACT Registered. The certificate issued by SGS was also verified by an independent certification board before issue.
Since pharmaceutical regulations require manufacturers to be certified against related standards, the EXCiPACT Certification Scheme simplifies the audits they must undergo. GMP and/or GDP compliance requires more audit burden and effort. This scheme becomes beneficial by providing simpler methodologies for drug manufacturers to be compliant.
For full details of all sites that have been EXCiPACT certified to date, in 17 Countries (China, Belgium, France, Germany, India, Israel, Italy, Japan, Romania, Saudi Arabia, Singapore, Spain, Switzerland, The Netherlands, UK and USA), see http://www.excipact.org/certificate-holders.html.
For more information, please contact:
Global Head International Sales and Accounts
t: +44 7889 939 725
SGS is the world's leading inspection, verification, testing and certification company. SGS is recognized as the global benchmark for quality and integrity. With more than 97,000 employees, SGS operates a network of over 2,600 offices and laboratories around the world.